Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schoppmann

Showing results (191-200 of 277) with videos related to

Pageof 28
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2013
No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibodyMatthias Preusser, Anna S Berghoff, David Capper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 24, 2012
Expression of BRAF V600E mutant protein in epithelial ovarian tumorsMatthias Preusser, David Capper, Anna S Berghoff, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 30, 2021
Expanded Indication for Magnetic Sphincter Augmentation: Outcomes in Weakly Acidic Reflux Compared to Standard GERD PatientsMilena Nikolic, Aleksa Matic, Joy Feka, et al.
The American Journal of Surgical Pathology|November 26, 2010
Expression of Her-2 in carcinomas of the esophagusSebastian F Schoppmann, Bettina Jesch, Julia Friedrich, et al.
European Radiology|June 5, 2015
Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancerDietmar Tamandl, Richard M Gore, Barbara Fueger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancerMonika Schindl, Sebastian F Schoppmann, Hellmut Samonigg, et al.
Cancer Biology & Therapy|December 19, 2017
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysisA Ilhan-Mutlu, H Taghizadeh, A Beer, et al.
Scientific Reports|May 11, 2018
Crural Closure improves Outcomes of Magnetic Sphincter Augmentation in GERD patients with Hiatal HerniaKatrin Schwameis, Milena Nikolic, Deivis G Morales Castellano, et al.
Anticancer Research|May 7, 2013
The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume centerKatrin Schwameis, Ahmed Ba-Ssalamah, Fritz Wrba, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 15, 2020
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidityMatthias Paireder, Gerd Jomrich, Ivan Kristo, et al.
Pageof 28

Showing results (191-200 of 277) with videos related to

Sort By:
Pageof 28
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2013
No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibodyMatthias Preusser, Anna S Berghoff, David Capper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 24, 2012
Expression of BRAF V600E mutant protein in epithelial ovarian tumorsMatthias Preusser, David Capper, Anna S Berghoff, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 30, 2021
Expanded Indication for Magnetic Sphincter Augmentation: Outcomes in Weakly Acidic Reflux Compared to Standard GERD PatientsMilena Nikolic, Aleksa Matic, Joy Feka, et al.
The American Journal of Surgical Pathology|November 26, 2010
Expression of Her-2 in carcinomas of the esophagusSebastian F Schoppmann, Bettina Jesch, Julia Friedrich, et al.
European Radiology|June 5, 2015
Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancerDietmar Tamandl, Richard M Gore, Barbara Fueger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancerMonika Schindl, Sebastian F Schoppmann, Hellmut Samonigg, et al.
Cancer Biology & Therapy|December 19, 2017
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysisA Ilhan-Mutlu, H Taghizadeh, A Beer, et al.
Scientific Reports|May 11, 2018
Crural Closure improves Outcomes of Magnetic Sphincter Augmentation in GERD patients with Hiatal HerniaKatrin Schwameis, Milena Nikolic, Deivis G Morales Castellano, et al.
Anticancer Research|May 7, 2013
The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume centerKatrin Schwameis, Ahmed Ba-Ssalamah, Fritz Wrba, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 15, 2020
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidityMatthias Paireder, Gerd Jomrich, Ivan Kristo, et al.
Pageof 28